Search
News Archive
Categories
Copalis launches Protein M+, a marine polysaccharide and collagen nutricosmetic ingredient
Posted On: March 9, 2011Copalis® launches Protein M+, an anti-aging nutricosmetic ingredient. Protein M+ is an all-natural marine polysaccharide and collagen complex. It combines the same proteins and polysaccharides as those found in skin for a synergic action. Collagen fibers give the dermis tensile strength, and polysaccharides prevent moisture loss. Protein M+’s extraction process makes it soluble in aqueous phase and fully digestible. Its high bioavailability makes it ideal for oral cosmetics.
Studies conducted by the company suggest overtime, Protein M+ may help visibly reduce the appearance of fine lines and wrinkles, dilated capillaries and age spots, thus improving skin’s moisture balance. In addition, results also show it helps repair sun-damaged skin. Several clinical studies conducted by Copalis suggest Protein M+, with added minerals and vitamins, is effective in the treatment of hair loss. While mechanism of action has yet to be proven, it is suggested the active marine complex is related to the production of dihydrotestosterone in the hair follicle. This molecule is known to cause hair loss.
Possibly the first world patent on abalone polysaccharide
Posted On: May 19, 2009This information was originally posted in the Aquapreneur Forum by our colleagues in China.
Abstract: An extraction method of abalone polysaccharide characterized in that abalone meat (including organs) is obtained. There is provided a technical basis for further research due to continuous intensive research on pharmaceutic use of abalone polysaccharide.
Details http://www.wipo.int/pctdb/en/wo.jsp?wo=2007041951
Starfish and Sea Worms to Help Develop Stem Cell Research
Posted On: May 11, 2009Marine biotechnology company GlycoMar Ltd has been awarded a £70,000 grant from the Scottish Government’s SMART: SCOTLAND programme to develop new products for growing human stem cells. The process involves the Oban-based company using blood withdrawn from marine invertebrates, including worms and starfish. The products prepared from this blood will then be tested in stem cell culture systems supplied by Roslin Cells in Edinburgh. The SMART: SCOTLAND grant enables GlycoMar to take its technology into the stem cell market for the first time. GlycoMar exploits natural products in marine invertebrates to advance human health. Dr Bavington believes that marine invertebrates are a suitable source to find novel stem cell media supplements. “This is because of their remarkable capacity for continual growth and regeneration throughout their life course, often from their own stem cell reservoirs,” he said. “Starfish, for example can re-grow their limbs.” The use of non-mammalian marine material also means there is a very low risk of cross contamination with pathogens such as BSE. This research and the collaboration between GlycoMar and Roslin Cells highlights the excellence of the research work being undertaken by stem cell community in Scotland and typifies the efforts of the SSCN to bring the relevant experts together in this exciting and constantly developing field.
Scottish Marine Biotech Firm and China Firm Link Up
Posted On: May 11, 2009Oban-based GlycoMar and Glasgow-based Scottish Biomedical have signed agreements with Chinese pharmaceutical giant Asiapharm to test and potentially license two of their lead products. The GlycoMar products have potential for the treatment of cardiovascular disease, while the Scottish Biomedical drugs could treat debilitating psychotic disorders such as schizophrenia. Scotland’s life sciences industry is one of the most vibrant in Europe – with about 600 organizations employing over 30,000 people. Under the terms of the deal, Asiapharm will carry out trials and further development of the two products. If successful, Asiapharm will license these products for the Chinese market.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
